KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Other Non Operating Income (2016 - 2025)

Omega Healthcare Investors' Other Non Operating Income history spans 8 years, with the latest figure at $27.5 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 38.34% year-over-year to $27.5 million; the TTM value through Dec 2025 reached $122.4 million, up 570.63%, while the annual FY2025 figure was $122.4 million, 570.63% up from the prior year.
  • Other Non Operating Income for Q4 2025 was $27.5 million at Omega Healthcare Investors, down from $45.1 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $296.4 million in Q4 2022 and bottomed at -$1.3 million in Q1 2024.
  • The 5-year median for Other Non Operating Income is $19.9 million (2024), against an average of $35.7 million.
  • The largest annual shift saw Other Non Operating Income crashed 21283.33% in 2024 before it surged 33017.52% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $60.4 million in 2021, then soared by 390.78% to $296.4 million in 2022, then plummeted by 100.16% to -$486000.0 in 2023, then soared by 4190.12% to $19.9 million in 2024, then skyrocketed by 38.34% to $27.5 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Other Non Operating Income are $27.5 million (Q4 2025), $45.1 million (Q3 2025), and $36.6 million (Q2 2025).